We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
1751
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $123K | ﹤0.01% |
5,800
+4,100
| +241% | +$72.4K |
|
|
ONEM
1752
DELISTED
1Life Healthcare
ONEM
| $123K | ﹤0.01% |
3,400
-1,500
| -31% | -$42.2K |
|
1753
Immunovant
IMVT
$8.09B
| $119K | ﹤0.01% |
+4,900
| New | +$105K |
|
|
ZYXI
1754
DELISTED
Zynex
ZYXI
| $119K | ﹤0.01% |
5,280
+2,420
| +85% | +$40.5K |
|
1755
Hasbro
HAS
$12.6B
| $118K | ﹤0.01% |
1,587
-8,024
| -83% | -$581K |
|
1756
Old National Bancorp
ONB
$10.1B
| $118K | ﹤0.01% |
8,600
-11,100
| -56% | -$150K |
|
1757
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $118K | ﹤0.01% |
+385
| New | +$113K |
|
1758
UMB Financial
UMBF
$10.7B
| $118K | ﹤0.01% |
2,300
-2,000
| -47% | -$98K |
|
|
AAMI
1759
Acadian Asset Management
AAMI
$2.88B
| $118K | ﹤0.01% |
9,500
+2,300
| +32% | +$18.8K |
|
1760
Cleveland-Cliffs
CLF
$6.81B
| $117K | ﹤0.01% |
21,300
+8,140
| +62% | +$39.6K |
|
1761
Genworth Financial
GNW
$3.8B
| $116K | ﹤0.01% |
50,300
| – | – |
|
1762
Children's Place
PLCE
$53.6M
| $116K | ﹤0.01% |
+3,100
| New | +$105K |
|
|
CTT
1763
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $116K | ﹤0.01% |
13,200
| – | – |
|
|
BRY
1764
DELISTED
Berry Corp
BRY
| $115K | ﹤0.01% |
24,000
-11,900
| -33% | -$46K |
|
1765
Lennox International
LII
$18.8B
| $114K | ﹤0.01% |
490
| – | – |
|
1766
Gold Fields
GFI
$29.2B
| $112K | ﹤0.01% |
12,000
| – | – |
|
|
ICAD
1767
DELISTED
iCAD Inc
ICAD
| $112K | ﹤0.01% |
+11,300
| New | +$122K |
|
1768
Option Care Health
OPCH
$3.4B
| $112K | ﹤0.01% |
8,100
| – | – |
|
1769
H.B. Fuller
FUL
$3B
| $111K | ﹤0.01% |
+2,500
| New | +$90.7K |
|
1770
Veracyte
VCYT
$4.52B
| $111K | ﹤0.01% |
4,300
+400
| +10% | +$9.97K |
|
|
EPAY
1771
DELISTED
Bottomline Technologies Inc
EPAY
| $111K | ﹤0.01% |
2,200
+1,300
| +144% | +$58.1K |
|
|
RAVN
1772
DELISTED
Raven Industries Inc
RAVN
| $111K | ﹤0.01% |
+5,200
| New | +$110K |
|
|
LDL
1773
DELISTED
Lydall, Inc.
LDL
| $111K | ﹤0.01% |
+8,200
| New | +$90.7K |
|
1774
Ally Financial
ALLY
$13.1B
| $110K | ﹤0.01% |
5,594
-80,425
| -93% | -$1.37M |
|
1775
Independent Bank
INDB
$4.05B
| $107K | ﹤0.01% |
1,600
-1,000
| -38% | -$67.2K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.